V. Cenacchi

发表

In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.

S. Ottonello, F. Grassi, B. Imbimbo, 2007, Pharmacological research.

Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology.

F. Acevedo, E. Selg, P. Puccini, 2017, Journal of aerosol medicine and pulmonary drug delivery.

Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.

A. Tarral, P. Dostert, I. Rondelli, 2007, British journal of clinical pharmacology.

LC-MS-MS determination of exemestane in human plasma with heated nebulizer interface following solid-phase extraction in the 96 well plate format.

C. James, V. Cenacchi, J. Long, 2000, Journal of pharmaceutical and biomedical analysis.

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

A. Sala, S. Catinella, Valentina Bagnacani, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration

A. Capelli, A. Virdis, F. Facchinetti, 2015, Steroids.

Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

S. Catinella, C. Bigogno, C. Parini, 2005, Journal of medicinal chemistry.

In vitro and in vivo metabolism of CHF 6001, a selective phosphodiesterase (PDE4) inhibitor

P. Puccini, B. Riccardi, D. Pezzetta, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Possible role of structural lipids in artificial nutrition: comparison of a linoleic acid-based with an oleic acid-based enteral formula in humans

P. Gionchetti, C. Guarnieri, L. Barbara, 1993 .

Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection.

D. Fraier, V. Cenacchi, E. Frigerio, 1998, Journal of chromatography. A.

Role of efflux transporters in the absorption, distribution and elimination in rodents of a novel PDE4 inhibitor, CHF6001

P. Puccini, B. Riccardi, G. Brogin, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

M. Zaniboni, G. Rossoni, G. Villetti, 2010, Journal of Pharmacology and Experimental Therapeutics.

Microsoft Word - 1192223-file00

M. Zaniboni, M. Civelli, F. Pastore, 2010 .

CHF5074, a novel γ‐secretase modulator, attenuates brain β‐amyloid pathology and learning deficit in a mouse model of Alzheimer's disease

M. Pizzi, B. Imbimbo, B. Hutter-Paier, 2009, British journal of pharmacology.

From the Lab to Real Life: Monitoring Cardiorespiratory Fitness during the COVID-19 Pandemic through Wearable Devices. An Exploratory Longitudinal Study on Healthy Participants

G. Pavei, V. Cenacchi, L. Ruggiero, 2022, Healthcare.

Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

Andrea Rizzi, Paola Puccini, Gino Villetti, 2005, Journal of medicinal chemistry.

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

S. Catinella, Valentina Bagnacani, F. Amadei, 2017, Journal of medicinal chemistry.

Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

S. Catinella, F. Amadei, P. Puccini, 2014, Journal of medicinal chemistry.

ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties

P. Puccini, G. Brogin, V. Cenacchi, 2023, Xenobiotica; the fate of foreign compounds in biological systems.

Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.

F. Amadei, P. Puccini, G. Villetti, 2023, Journal of medicinal chemistry.

In vitro and in vivo metabolism of CHF 6001, a selective phosphodiesterase (PDE4) inhibitor

P. Puccini, B. Riccardi, D. Pezzetta, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.

F. Amadei, P. Puccini, G. Villetti, 2021, Journal of medicinal chemistry.

Determination of PNU-248686A, a novel matrix metalloproteinase inhibitor, in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format.

C. James, V. Cenacchi, E. Frigerio, 2003, Journal of chromatography. A.